Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	57106	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	57612	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	60763	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	70470	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	72717	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	72988	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	75365	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	79688	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	83412	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	87391	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	90346	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	91059	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	100928	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	104818	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	104935	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	106125	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	106647	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	106740	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	109490	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	109838	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	110868	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	111152	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	112805	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	113997	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	115173	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	116043	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	117259	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	118968	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	119821	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	120748	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	125181	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	125233	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	126672	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	127895	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	128373	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	128444	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	129175	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	130307	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	130601	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	131232	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	131581	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	132049	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	134198	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	137122	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	137138	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	137260	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	137937	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	138602	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	140626	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	143318	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	145584	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	152380	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	152793	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	155239	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	155748	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	157922	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	157988	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	158339	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	158486	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	161619	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	162065	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	162757	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	162804	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	163494	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	164004	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	165390	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	165561	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	166817	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	169320	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	171148	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	171749	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	172259	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	173375	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	174137	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	174864	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	175530	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	178852	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	180698	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	187738	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	188056	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	188866	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	189157	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	192788	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	198015	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	198321	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	198765	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	202394	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	202557	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	204679	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	204888	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	207712	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	211271	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	211445	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	216419	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	233250	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	238234	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	245631	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	250553	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	335642	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	HEPTADECANOATE (CAS# 506-12-7); (M-H)-	356931	Peak area	Control	N	Letrozole	White	Baseline	Y	N